Chemotherapy in the treatment of neuroendocrine malignant tumors.
about
The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma.90Y-edotreotide for metastatic carcinoid refractory to octreotide.The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours.Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.From basic to clinical research in gastroenteropancreatic neuroendocrine tumor disease -- the clinician-scientist perspective.Lymph nodes and survival in pancreatic neuroendocrine tumors.Treatment of Zollinger-Ellison syndrome.Carcinoid syndrome: diagnosis and medical management.Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo: challenges and prospects.Malignant neuroendocrine tumour of the gallbladder with elevated carcinoembryonic antigen: case report and literature review.Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas.Primary carcinoid tumour of nasal septum.Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver.Periampullary mass--a rare presentation of poorly differentiated neuroendocrine cancer of duodenum in a young adult: a case report and review of literature.Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types.Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.[Metastatic neuroendocrine neoplasms. Non-surgical treatment strategies].
P2860
Q33290258-794943FA-A78B-4546-B7EA-E81152E3AC2FQ34101554-C68FE435-226C-4595-8365-3DEEC76AF9E4Q34564262-F1D092C6-95F7-4A39-AF4C-3DE8DDE93314Q34769975-3A25524B-70CB-4374-BD3B-99DA4C0D8123Q35915032-199A4075-AF58-4BF5-92C6-C8A40A3E6073Q36250472-662BCF7D-0EEA-4B8E-92AA-4845C5A657D6Q36285347-0027EBC1-DDB5-49B3-9823-34A068063841Q36380878-F5416200-56AE-4F5E-A9FB-0C5285147BC7Q36685485-FE0C135F-E094-440F-86CB-2024A855B32DQ36893968-5F1DF565-4590-48CF-A124-93E1DA42CBC7Q37246147-075F6FF0-9C23-49DE-AAC0-997F81515202Q37257786-678D924B-E2F3-4269-AF8D-9B9600FCB954Q37856906-1C2866EA-2EF1-49C3-93E9-BC82B56667A4Q38050716-AA2F4035-8841-4DAC-AA33-3D476FA77B56Q43493958-931EF2DF-E853-4B31-936E-A48C798396ACQ43921041-92EFB424-CC68-4847-8731-2210AD0A329EQ44479307-800703AE-6A82-494C-BB20-CF879084CE4EQ52894194-043F7D60-E87E-4174-A2B9-B925E1C9C93D
P2860
Chemotherapy in the treatment of neuroendocrine malignant tumors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Chemotherapy in the treatment of neuroendocrine malignant tumors.
@ast
Chemotherapy in the treatment of neuroendocrine malignant tumors.
@en
Chemotherapy in the treatment of neuroendocrine malignant tumors.
@nl
type
label
Chemotherapy in the treatment of neuroendocrine malignant tumors.
@ast
Chemotherapy in the treatment of neuroendocrine malignant tumors.
@en
Chemotherapy in the treatment of neuroendocrine malignant tumors.
@nl
prefLabel
Chemotherapy in the treatment of neuroendocrine malignant tumors.
@ast
Chemotherapy in the treatment of neuroendocrine malignant tumors.
@en
Chemotherapy in the treatment of neuroendocrine malignant tumors.
@nl
P356
P1433
P1476
Chemotherapy in the treatment of neuroendocrine malignant tumors.
@en
P2093
P356
10.1159/000051859
P478
62 Suppl 1
P577
2000-01-01T00:00:00Z